Suffolk Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Suffolk Capital Management's BIIB Position: Q4 2018 in Review
Suffolk Capital Management sold out of Biogen (BIIB) in Q4 2018, closing a stake of 38,917 shares — an estimated $13.8M sold.
Suffolk Capital Management first reported a position in BIIB in Q1 2014 and held it in 12 quarters. The position peaked at $13.8M in Q3 2018. 1,140 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.
- Suffolk Capital Management reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
- Suffolk Capital Management sold 38,917 Biogen shares in Q4 2018, an estimated $13.8M.
- Suffolk Capital Management first reported a position in Biogen in Q1 2014 and held it in 12 quarters.
- Suffolk Capital Management's Biogen position peaked at $13.8M in Q3 2018.
- 1,140 funds tracked by Wall St. Rank held Biogen as of Q4 2018.
Based on Suffolk Capital Management's 13F filing for Q4 2018, filed 23 Jan 2019.